THOUSAND OAKS, Calif., May 2, 2024 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the first quarter 2024. “With many of our innovative products delivering strong growth and promising new medicines advancing through our pipeline, we are excited about delivering…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
